Cryptococcal Antigenemia and the Implications of Viral Load-Directed Cryptococcal Antigen Screening in Antiretroviral Therapy-Experienced Patients With Human Immunodeficiency Virus
- PMID: 33069168
- PMCID: PMC11891446
- DOI: 10.1093/cid/ciaa1565
Cryptococcal Antigenemia and the Implications of Viral Load-Directed Cryptococcal Antigen Screening in Antiretroviral Therapy-Experienced Patients With Human Immunodeficiency Virus
Conflict of interest statement
Comment in
-
Reply to the Author.Clin Infect Dis. 2021 Nov 2;73(9):e2820. doi: 10.1093/cid/ciaa1566. Clin Infect Dis. 2021. PMID: 33069167 Free PMC article. No abstract available.
Comment on
-
Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy-Experienced Ugandans With Virologic Failure.Clin Infect Dis. 2020 Oct 23;71(7):1726-1731. doi: 10.1093/cid/ciz1069. Clin Infect Dis. 2020. PMID: 31679007 Free PMC article.
References
-
- World Health Organization. Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. WHO Guidelines Approved by the Guidelines Review Committee. Geneva, Switzerland: WHO, 2018. - PubMed
-
- World Health Organization. Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy. WHO guidelines approved by the Guidelines Review Committee. Geneva, Switzerland: WHO, 2017. - PubMed
-
- Meya DB, Kiragga AN, Nalintya E, et al. Reflexive laboratory-based cryptococcal antigen screening and preemptive fluconazole therapy for cryptococcal antigenemia in HIV-infected individuals with CD4 <100 cells/μL: a stepped-wedge, cluster-randomized trial. J Acquir Immune Defic Syndr 2019; 80:182–9. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
